-IR- Database Guide
Indiana General Assembly

Administrative Rules
Drafting Manual

Emergency Authority List
Indiana Register  
Current IR
Archive
Indiana Administrative Code
Latest Update
Archive
IR and IAC Search
Enter search terms
All Registers
Latest Update IAC
Advanced Search
Register DIN
(Document ID Number)
Enter the full DIN, example:
20060301-IR-025050010NIA
LSA Document #
(Documents since July 2, 2006)
-  
Example: 06 - 121
IAC Cite
  - IAC -   
Enter Title and Article (optional)
example: 45 - IAC - 1
Indiana Code Cite
 -  -  -  
Enter Title, Article*, Chapter*, and Section*
* = optional
example: 4 - 22 - 8 - 2

-IR- Database: Indiana Register

Register Documents associated with
LSA Document number 17-283

(Only documents posted after July 2, 2006 will be found.)
Title 856  Indiana Board of Pharmacy
      DIN: 20190123-IR-856170283WDA ( HTML - PDF )
      Type: WD  Posted: 01/23/2019   LSA Doc #17-283  Title 856 
Under IC 4-22-2-41, LSA Document #17-283, posted at 20181024-IR-856170283PRA, is withdrawn.
 
      DIN: 20181024-IR-856170283EIA ( HTML - PDF )
      Type: EI  Posted: 10/24/2018   LSA Doc #17-283  Title 856 
Economic Impact Statement LSA Document #17-283
 
      DIN: 20181024-IR-856170283PHA ( HTML - PDF )
      Type: PH  Posted: 10/24/2018   LSA Doc #17-283  Title 856 
Notice of Public Hearing LSA Document #17-283
 
      DIN: 20181024-IR-856170283PRA ( HTML - PDF )
      Type: PR  Posted: 10/24/2018   LSA Doc #17-283  Title 856 
Adds 856 IAC 1-43, concerning ephedrine and pseudoephedrine, to establish requirements concerning the sale of products containing ephedrine or pseudoephedrine by pharmacists and to establish requirem...
 
      DIN: 20180214-IR-856170283ARA ( HTML - PDF )
      Type: AR  Posted: 02/14/2018   LSA Doc #17-283  Title 856 
One Year Requirement (IC 4-22-2-25) LSA Document #17-283
 
      DIN: 20170614-IR-856170283NIA ( HTML - PDF )
      Type: NI  Posted: 06/14/2017   LSA Doc #17-283  Title 856 
OVERVIEW: Adds 856 IAC 1-43 concerning ephedrine and pseudoephedrine. The rule will establish requirements concerning the sale of products containing ephedrine or pseudoephedrine by pharmacists. The ...